Generated by AI
Pfizer Inc. is a global biopharmaceutical company that discovers, develops, manufactures, and markets medicines and vaccines for people worldwide. Its current portfolio spans oncology, vaccines, internal medicine, inflammation and immunology, rare diseases, and hospital-based care, supported by a broad commercial network that serves physicians, hospitals, pharmacies, governments, and healthcare systems. Pfizer also maintains a consumer health presence through established over-the-counter and wellness products in select markets. The company plays a central role in global healthcare by supplying prescription therapies and immunizations across major therapeutic areas, while its research and development organization continues to support the launch, approval, and lifecycle management of new treatments. Founded in 1849 and headquartered in New York City, Pfizer Inc. remains one of the most recognized names in the pharmaceutical industry.
Website66 Hudson Boulevard East
New York, NY, 10001-2192
United States
The latest articles about PFE.
Analyst rates Pfizer Inc. a Buy as oncology, Eliquis and tafamidis may offset its three-year patent cycle; 2026 EPS guidance rises to $2.95-$3.05.
Pfizer (PFE) pays China-based Starna Therapeutics $330M upfront to receive ex-China rights to CAR-T drugs in a deal worth up to $2.6B. Read more here.
Summary of Nov 18's posts. Generated by AI.
Summary of Nov 17's posts. Generated by AI.
Summary of May 6's posts. Generated by AI.
Summary of Nov 17's posts. Generated by AI.
Investors talking about PFE also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.